Evidence map›Paper›PMID 31778743›Full record

ArticleBrain, behavior, and immunity2020

Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in late sepsis.

Divine C Nwafor, Sreeparna Chakraborty, Allison L Brichacek, Sujung Jun, Catheryne A Gambill, Wei Wang, Elizabeth B Engler-Chiurazzi, Duaa Dakhlallah, Anthony B Pinkerton, José Luis Millán and 2 more

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Divine C NwaforDepartment of Neuroscience, West Virginia University Health Science Center, Morgantown, WV 26506, USA. Electronic address: dnwafor@mix.wvu.edu.
Sreeparna ChakrabortyDepartment of Microbiology, Immunology, and Cell Biology, School of Medicine, West Virginia University Health Science Center, Morgantown, WV 26506, USA.
Allison L BrichacekDepartment of Microbiology, Immunology, and Cell Biology, School of Medicine, West Virginia University Health Science Center, Morgantown, WV 26506, USA. Electronic address: alb0037@mix.wvu.edu.
Sujung JunWilmer Eye Institute, John Hopkins University School of Medicine, Baltimore, MD 21231, USA. Electronic address: sjun6@jhmi.edu.
Catheryne A GambillDepartment of Microbiology, Immunology, and Cell Biology, School of Medicine, West Virginia University Health Science Center, Morgantown, WV 26506, USA. Electronic address: cag0030@mix.wvu.edu.
Wei WangDepartment of Neuroscience, West Virginia University Health Science Center, Morgantown, WV 26506, USA. Electronic address: wgwang@hsc.wvu.edu.
Elizabeth B Engler-ChiurazziDepartment of Neuroscience, West Virginia University Health Science Center, Morgantown, WV 26506, USA. Electronic address: elengler@hsc.wvu.edu.
Duaa DakhlallahDepartment of Neuroscience, West Virginia University Health Science Center, Morgantown, WV 26506, USA; Cancer Institute, West Virginia University Health Science Center, Morgantown, WV 26506, USA. Electronic address: duaa.dakhlallah@hsc.wvu.edu.
Anthony B PinkertonSanford-Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address: apinkerton@sbpdiscovery.org.
José Luis MillánSanford-Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address: millan@sbpdiscovery.org.
Stanley A BenkovicDepartment of Neuroscience, West Virginia University Health Science Center, Morgantown, WV 26506, USA.
Candice M BrownDepartment of Neuroscience, West Virginia University Health Science Center, Morgantown, WV 26506, USA; Department of Microbiology, Immunology, and Cell Biology, School of Medicine, West Virginia University Health Science Center, Morgantown, WV 26506, USA. Electronic address: cdbrown2@hsc.wvu.edu.
West Virginia University · USDiscovery Institute · USJohns Hopkins Medicine · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI Trupti Joshi · 2012 to 2026
$61.1M
West Virginia University Stroke COBREP20GM109098 · NIGMS · WEST VIRGINIA UNIVERSITY · PI HRUSKA, MARTIN · 2014 to 2024
$24.5M
MOLECULAR PATHOGENESIS/TREATMENT OF HYPOPHOSPHATASIAR01DE012889 · NIDCR · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MILLAN, JOSE LUIS · 1999 to 2020
$9.2M
West Virginia Flow Cytometry Core FacilityP30GM103488 · NIGMS · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2012 to 2016
$4.8M
Stroke and Alzheimers Disease Related DementiasT32AG052375 · NIA · WEST VIRGINIA UNIVERSITY · PI Paul D Chantler, BERNARD G. SCHREURS · 2017 to 2026
$3.5M
Estradiol Regulation of Brain-Microvascular Inflammatory Responses in SepsisK01NS081014 · NINDS · WEST VIRGINIA UNIVERSITY · PI BROWN, CANDICE · 2012 to 2016
$714k
Assessment of Mechanisms Underlying B Cell Impacts on Resilience and Susceptibility to StressK01MH117343 · NIMH · WEST VIRGINIA UNIVERSITY · PI ENGLER-CHIURAZZI, ELIZABETH · 2020 to 2023
$576k
Special Becton Dickinson Fortessa Flow CytometerS10OD016165 · OD · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2013 to 2013
$384k
NIA NIH HHS T32 AG052375NIDCR NIH HHS R01 DE012889NIGMS NIH HHS P20 GM103434NIGMS NIH HHS P20 GM109098NIGMS NIH HHS P30 GM103488NIGMS NIH HHS U54 GM104942NIH HHS S10 OD016165NIMH NIH HHS K01 MH117343NINDS NIH HHS K01 NS081014
6 · The paper itself

Abstract

Sepsis is a host response to systemic inflammation and infection that may lead to multi-organ dysfunction and eventual death. While acute brain dysfunction is common among all sepsis patients, chronic neurological impairment is prevalent among sepsis survivors. The brain microvasculature has emerged as a major determinant of sepsis-associated brain dysfunction, yet the mechanisms that underlie its associated neuroimmune perturbations and behavioral deficits are not well understood. An emerging body of data suggests that inhibition of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels may be associated with changes in endothelial cell barrier integrity. The objective of this study was to elucidate the connection between alterations in cerebrovascular TNAP enzyme activity and brain microvascular dysfunction in late sepsis. We hypothesized that the disruption of TNAP enzymatic activity in cerebral microvessels would be coupled to the sustained loss of brain microvascular integrity, elevated neuroinflammatory responses, and behavioral deficits. Male mice were subjected to cecal ligation and puncture (CLP), a model of experimental sepsis, and assessed up to seven days post-sepsis. All mice were observed daily for sickness behavior and underwent behavioral testing. Our results showed a significant decrease in brain microvascular TNAP enzyme activity in the somatosensory cortex and spinal cord of septic mice but not in the CA1 and CA3 hippocampal regions. Furthermore, we showed that loss of cerebrovascular TNAP enzyme activity was coupled to a loss of claudin-5 and increased perivascular IgG infiltration in the somatosensory cortex. Analyses of whole brain myeloid and T-lymphoid cell populations also revealed a persistent elevation of infiltrating leukocytes, which included both neutrophil and monocyte myeloid derived suppressor cells (MDSCs). Regional analyses of the somatosensory cortex, hippocampus, and spinal cord revealed significant astrogliosis and microgliosis in the cortex and spinal cord of septic mice that was accompanied by significant microgliosis in the CA1 and CA3 hippocampal regions. Assessment of behavioral deficits revealed no changes in learning and memory or evoked locomotion. However, the hot plate test uncovered a novel anti-nociceptive phenotype in our septic mice, and we speculate that this phenotype may be a consequence of sustained GFAP astrogliosis and loss of TNAP activity in the somatosensory cortex and spinal cord of septic mice. Taken together, these results demonstrate that the loss of TNAP enzyme activity in cerebral microvessels during late sepsis is coupled to sustained neuroimmune dysfunction which may underlie, in part, the chronic neurological impairments observed in sepsis survivors.

Indexed as

Alkaline PhosphataseAnimalsBrainCell LineDisease Models, AnimalHumansInflammationMaleMiceMice, Inbred C57BLMicrovesselsSepsisAlkaline PhosphataseAstrogliosisBlood–brain barrierCecal ligation and punctureMicrogliosisNeuroimmuneNociceptionSepsisTissue non-specific alkaline phosphatase

Identifiers

PMID31778743
PMCPMC7010562
OpenAlexW2989940097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.